Planta Med 2023; 89(14): 1384-1385
DOI: 10.1055/s-0043-1774147
Abstracts
Tuesday 4th July 2023 | Poster Session II
Phytopharmacology II – Metabolism; Diabetes; Obesity; Gut

Evaluation of antioxidant and antidiabetic activities of Trigonella foenum-graecum phytoestrogen-rich extracts

Gabriela Paun
1   National Institute For Research-development Of Biological Sciences, Bucharest, Romania
,
Elena Neagu
1   National Institute For Research-development Of Biological Sciences, Bucharest, Romania
,
Camelia Albu
1   National Institute For Research-development Of Biological Sciences, Bucharest, Romania
,
Oana Teodora Apreutesei
2   Centrul de Cercetare si Prelucrare a Plantelor Medicinale PLANTAVOREL S.A, Piatra Neamt, Romania
,
Gabriel Lucian Radu
1   National Institute For Research-development Of Biological Sciences, Bucharest, Romania
› Institutsangaben
 
 

Trigonella foenum-graecum has long been used in traditional medicine for different diseases. Recent studies highlighted the antidiabetic activity of fenugreek seeds linked to the presence of trigonelline alkaloid and galactomannan polysaccharides [1] [2]. In this study, T. foenum-graecum extract was obtained by accelerated solvent extraction (ASE), and processed by microfiltration and nanofiltration in a tangential module, using a membrane with MWCO 150-300 Da for concentrating the phytoestrogen compounds. Some of the most important phytoestrogens are flavonoids and isoflavonoids. Plant extracts were evaluated for phytochemical profile (phenolics, flavonoids, isoflavonoids), antioxidant (DPPH• and reducing power assays), α-amylase and α-glucosidase inhibition. The HPLC-MS analysis showed that the T. foenum-graecum phytoestrogen-rich extract contains mainly vitexin, rutin and isoquercitrin. The studied extract exhibited a high antioxidant capacity in DPPH inhibition (85.7±0.6%) and reducing power assay (94.7%). The T. foenum-graecum phytoestrogen-rich extract showed significant α-amylase (IC50=9.71 µg/mL) and α- glucosidase (IC50=28.19 µg/mL) inhibitory activities, compared to acarbose as control (IC50=24.18 µg/mL and 798.32 µg/mL, respectively). Furthermore, combinations of isoflavones with other bioactive compounds from the concentrated extract could act synergistically and the T. foenum-graecum phytoestrogen-rich extract could be a feasible source of nutraceuticals.

Funding This work was supported by a grant of the Ministry of Research, Innovation and Digitization, CCCDI – UEFISCDI, project number PN-III-P2-2.1-PED-2021-1185, within PNCDI III.



Publikationsverlauf

Artikel online veröffentlicht:
16. November 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany